Sign in
4/A

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001702626-19-000006

Exec. Vice Chairman/CEO/Pres. bought 29,404 shares at $4.03 ($118,498)

From the SEC's structured data for this filing

Trades in this filing

EQUELS THOMAS K. · Exec. Vice Chairman/CEO/Pres.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-06-21 Purchase : show line 1 in the form +29,404 $4.03 $118,498 60,409 D
Open-market purchases · 29,404 sh · avg $4.03 · $118,498
Loading xslF345X03/primary_doc.xml…